Published :
Tables : 45
Figures : 44
Category : Healthcare
No. of Pages : 210
Report Code : HC-U3249
COVID-19 Diagnostic Kits Market Introduction: Viral infections are diagnosed by testing the blood, an infected body specimen or body fluids and these samples are examined with an electron microscope. Based on the symptoms, infections like zika and measles are diagnosed and treated accordingly. There has been a rise in the prevalence rate of infectious diseases over the last decade and with the current COVID-19 outbreak, the demand for diagnostic kits has skyrocketed, thereby contributing to the growth of the market. Furthermore, increasing geriatric population is one primary reason for the rise in the number of COVID-19 patients worldwide. As per the WHO, over 90% of the deaths are of patients aged 55 and older and countries like Germany and Italy have a major share of population that is aged 55 or older which has increased the spread of the virus. Many diagnostic kit manufacturers are taking substantial steps in fulfilling the demand for diagnostic test kits, especially in countries where the patient numbers are rising with a remarkable rate. SD Biosensor, a South Korean diagnostic kit manufacturer, have initiated to manufacture rapid antibody test kits in India for detecting COVID-19 as early as possible. SD Biosensor received its license for manufacturing the diagnostic kits from ICMR on April 14 and then Drug Controller general of India sanctioned their license on April 16. They started manufacturing kits in their Manesar and they plan to produce over 500,000 kits per week. Furthermore, Siemens has planned to produce over 100,000 kits in India, and they donated over 40,000 test kits to ICMR under their Siemens Fight COVID-19 initiative. Moreover, South Korean manufacturer Seegene is expected to initiate the supply of over 1 million test kits to India in April. Similarly, Mologic has received a grant from the British government to develop COVID-19 testing kits that can diagnose the virus in ten minutes. They have partnered with Institut Pasteur de Dakar manufacture the kits in the custom-built epidemic innovation facility located in Dakar, Senegal. The North America region is expected to hold the largest COVID-19 diagnostic kits market share, and this is primarily owing to the rising number of COVID-19 patients where over 40,000 deaths are currently registered. Furthermore, many key market players in the region are planning of ramping up the production of testing kits. Thermo Fisher Scientific has declared to increase the production of COVID-19 detection kits based on RT-PCR method in March 2020 to meet UK’s demand of over 100,000 test every day. Some of the key market players are Abbott Laboratories, Seegene, Mylab Discovery Solutions, BGI, SD Biosensor, BioFire Diagnostics, Cepheid, Co-Diagnostics GenMark Diagnostics, Guangzhou Wondfo Biotech, , F. Hoffmann-La Roche, Qiagen, Quidel Corporation, Randox Laboratories, Shenzhen Bioeasy Biotechnology and Thermo Fisher Scientific. COVID-19 Diagnostic Kits Market Segmentation: By Product RT-PCR Assay Kits Immunoassay test Strips By Specimen Nasopharyngeal Swab Oropharyngeal Swab Nasal Swab Others By End User Hospitals Diagnostic Centres Others By Region North America Europe Asia Pacific Latin America Middle East And Africa FutureWise Key Takeaways: Growth prospects SWOT analysis Key market trends Key data-points affecting market growth Objectives of the Study: To provide with an exhaustive analysis on the global COVID-19 diagnostic kits market by product, by specimen, by end user and by region To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints) To evaluate and forecast micro-markets and the overall market To predict the market size, in key regions (along with countries)— North America, Europe, Asia Pacific, Latin America and Middle East and Africa To record, evaluate and analyze competitive landscape mapping- product launches, technological advancements, mergers and expansions Flexible Delivery Model: We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement The customization Mobility Care offered are free of charge with purchase of any license of the report You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com
Viral infections are diagnosed by testing the blood, an infected body specimen or body fluids and these samples are examined with an electron microscope. Based on the symptoms, infections like zika and measles are diagnosed and treated accordingly. There has been a rise in the prevalence rate of infectious diseases over the last decade and with the current COVID-19 outbreak, the demand for diagnostic kits has skyrocketed, thereby contributing to the growth of the market. Furthermore, increasing geriatric population is one primary reason for the rise in the number of COVID-19 patients worldwide. As per the WHO, over 90% of the deaths are of patients aged 55 and older and countries like Germany and Italy have a major share of population that is aged 55 or older which has increased the spread of the virus.
Many diagnostic kit manufacturers are taking substantial steps in fulfilling the demand for diagnostic test kits, especially in countries where the patient numbers are rising with a remarkable rate. SD Biosensor, a South Korean diagnostic kit manufacturer, have initiated to manufacture rapid antibody test kits in India for detecting COVID-19 as early as possible. SD Biosensor received its license for manufacturing the diagnostic kits from ICMR on April 14 and then Drug Controller general of India sanctioned their license on April 16. They started manufacturing kits in their Manesar and they plan to produce over 500,000 kits per week.
Furthermore, Siemens has planned to produce over 100,000 kits in India, and they donated over 40,000 test kits to ICMR under their Siemens Fight COVID-19 initiative. Moreover, South Korean manufacturer Seegene is expected to initiate the supply of over 1 million test kits to India in April. Similarly, Mologic has received a grant from the British government to develop COVID-19 testing kits that can diagnose the virus in ten minutes. They have partnered with Institut Pasteur de Dakar manufacture the kits in the custom-built epidemic innovation facility located in Dakar, Senegal.
The North America region is expected to hold the largest COVID-19 diagnostic kits market share, and this is primarily owing to the rising number of COVID-19 patients where over 40,000 deaths are currently registered. Furthermore, many key market players in the region are planning of ramping up the production of testing kits. Thermo Fisher Scientific has declared to increase the production of COVID-19 detection kits based on RT-PCR method in March 2020 to meet UK’s demand of over 100,000 test every day.
Some of the key market players are Abbott Laboratories, Seegene, Mylab Discovery Solutions, BGI, SD Biosensor, BioFire Diagnostics, Cepheid, Co-Diagnostics GenMark Diagnostics, Guangzhou Wondfo Biotech, , F. Hoffmann-La Roche, Qiagen, Quidel Corporation, Randox Laboratories, Shenzhen Bioeasy Biotechnology and Thermo Fisher Scientific.
COVID-19 Diagnostic Kits Market Segmentation:
By Product
By Specimen
By End User
By Region
FutureWise Key Takeaways:
Objectives of the Study:
Flexible Delivery Model:
1. Market Introduction 1.1 Objectives of the Study 1.2 Market Definition 1.3 Market Scope 1.3.1 Years Considered for the Study 1.3.2 Market Covered 1.4 Currency 1.5 Limitations 1.6 Stakeholders 2. Research Methodology 2.1 Research Data 2.1.1 Secondary Data 2.1.1.1 Key Data From Secondary Sources 2.1.2 Primary Data 2.1.2.1 Key Data From Primary Sources 2.2 Market Size Estimation 2.3 Market Breakdown and Data Triangulation 2.4 Assumptions for the Study 3. Executive Summary 3.1 Market Outlook 3.2 Segment Outlook 3.3 Competitive Insights 4. Global COVID-19 Diagnostic Kits Market Variables, Trends & Scope 4.1. Market Lineage Outlook 4.2. Penetration and Growth Prospect Mapping 4.3. Industry Value Chain Analysis 4.4. Cost Analysis Breakdown 4.5. Technology Overview 4.6. Regulatory Framework 4.6.1. Reimbursement Framework 4.6.2. Standards And Compliances 5. Global COVID-19 Diagnostic Kits Market Overview 5.1. Market Dynamics 5.1.1. Market Driver Analysis 5.1.1.1. Increasing focus of COVID-19 Diagnostic Kits Companies on Brand Protection 5.1.1.2. Untapped Opportunities in Emerging Regions 5.1.2. Market Restraint Analysis 5.1.2.1. High Cost Associated with Implementation of Predictive Analysis 5.1.3. Industry Challenges 5.1.3.1. Presence of Ambiguous Regulatory Framework 6. Global COVID-19 Diagnostic Kits Market Analysis Tools 6.1. Industry Analysis - Porter’s 6.1.1. Supplier Power 6.1.2. Buyer Power 6.1.3. Substitution Threat 6.1.4. Threat from New Entrants 6.1.5. Competitive Rivalry 6.2. Pestel Analysis 6.2.1. Political Landscape 6.2.2. Environmental Landscape 6.2.3. Social Landscape 6.2.4. Technology Landscape 6.2.5. Legal Landscape 6.3. Major Deals And Strategic Alliances Analysis 6.3.1. Joint Ventures 6.3.2. Mergers and Acquisitions 6.3.3. Licensing and Partnership 6.3.4. Technology Collaborations 6.3.5. Strategic Divestments 6.4. Market Entry Strategies 6.5. Case Studies 7. Global COVID-19 Diagnostic Kits Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million) 7.1. RT-PCR Assay Kits 7.2. Immunoassay Test Strips 8. Global COVID-19 Diagnostic Kits Market, By Specimen Historical Analysis and Forecast 2020-2027 (USD Million) 8.1. Nasopharyngeal Swab 8.2. Oropharyngeal Swab 8.3. Nasal Swab 8.4. Others 9. Global COVID-19 Diagnostic Kits Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million) 9.1. Hospitals 9.2. Diagnostics Centres 9.3 Others 10. North America COVID-19 Diagnostic Kits Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 10.1. Introduction 10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 10.2.1. U.S.A 10.2.2. Canada 10.2.3. Mexico 10.3. Market Size (USD Million) Forecast for North America 2020-2027 11. Latin America COVID-19 Diagnostic Kits Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 11.1. Introduction 11.2. Regional Market Trends 11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019 11.3.1. Brazil 11.3.2. Venezuela 11.3.3. Argentina 11.3.4. Rest of Latin America 11.4. Market Size (USD Million) Forecast for Latin America 2020-2027 12. Europe COVID-19 Diagnostic Kits Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 12.1. Introduction 12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 12.2.1. Germany 12.2.2. U.K 12.2.3. France 12.2.4. Italy 12.2.5. Spain 12.2.6. Russia 12.2.7. Poland 12.2.8. Switzerland 12.2.9. Rest of Western Europe 12.3. Market Size (USD Million) Forecast for Europe 2020-2027 13. Asia Pacific COVID-19 Diagnostic Kits Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 13.1. Introduction 13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 13.2.1. Japan 13.2.2. China 13.2.3. Singapore 13.2.4. India 13.2.5. Australia and New Zealand 13.2.6. ASEAN 13.2.7. South Korea 13.2.8. Taiwan 13.2.9. Rest of Asia Pacific 13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027 14. Middle East and Africa COVID-19 Diagnostic Kits Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million) 14.1. Introduction 14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019 14.2.1. Saudi Arabia 14.2.2. UAE 14.2.3. South Africa 14.2.4. Egypt 14.3. Market Size (USD Million) Forecast for MEA 2020-2027 15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts) 15.1. Abbott Laboratories 15.1.1. Company Overview 15.1.2. Product Portfolio 15.1.3. SWOT Analysis 15.1.4. Financial Overview 15.1.5. Strategic Overview 15.2. Seegene 15.2.1. Company Overview 15.2.2. Product Portfolio 15.2.3. SWOT Analysis 15.2.4. Financial Overview 15.2.5. Strategic Overview 15.3. Mylab Discovery Solutions 15.3.1. Company Overview 15.3.2. Product Portfolio 15.3.3. SWOT Analysis 15.3.4. Financial Overview 15.3.5. Strategic Overview 15.4. BGI 15.4.1. Company Overview 15.4.2. Product Portfolio 15.4.3. SWOT Analysis 15.4.4. Financial Overview 15.4.5. Strategic Overview 15.5 SD Biosensor 15.5.1. Company Overview 15.5.2. Product Portfolio 15.5.3. SWOT Analysis 15.5.4. Financial Overview 15.5.5. Strategic Overview 15.6 BioFire Diagnostics 15.6.1. Company Overview 15.6.2. Product Portfolio 15.6.3. SWOT Analysis 15.6.4. Financial Overview 15.6.5. Strategic Overview 15.7. Cepheid 15.7.1. Company Overview 15.7.2. Product Portfolio 15.7.3. SWOT Analysis 15.7.4. Financial Overview 15.7.5. Strategic Overview 15.8. Co-Diagnostics GenMark Diagnostics 15.8.1. Company Overview 15.8.2. Product Portfolio 15.8.3. SWOT Analysis 15.8.4. Financial Overview 15.8.5. Strategic Overview 15.9. Guangzhou Wondfo Biotech 15.9.1. Company Overview 15.9.2. Product Portfolio 15.9.3. SWOT Analysis 15.9.4. Financial Overview 15.9.5. Strategic Overview 15.10. F. Hoffmann-La Roche 15.10.1. Company Overview 15.10.2. Product Portfolio 15.10.3. SWOT Analysis 15.10.4. Financial Overview 15.10.5. Strategic Overview 15.11 Qiagen 15.11.1. Company Overview 15.11.2. Product Portfolio 15.11.3. SWOT Analysis 15.11.4. Financial Overview 15.11.5. Strategic Overview 15.12. Quidel Corporation 15.12.1. Company Overview 15.12.2. Product Portfolio 15.12.3. SWOT Analysis 15.12.4. Financial Overview 15.12.5. Strategic Overview 15.13. Randox Laboratories 15.13.1. Company Overview 15.13.2. Product Portfolio 15.13.3. SWOT Analysis 15.13.4. Financial Overview 15.13.5. Strategic Overview 15.14. Shenzhen Bioeasy Biotechnology 15.14.1. Company Overview 15.14.2. Product Portfolio 15.14.3. SWOT Analysis 15.14.4. Financial Overview 15.14.5. Strategic Overview 15.15. Thermo Fisher Scientific 15.15.1. Company Overview 15.15.2. Product Portfolio 15.15.3. SWOT Analysis 15.15.4. Financial Overview 15.15.5. Strategic Overview 16. FutureWise SME Key Takeaway Points for Client
1. Market Introduction
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Years Considered for the Study
1.3.2 Market Covered
1.4 Currency
1.5 Limitations
1.6 Stakeholders
2. Research Methodology
2.1 Research Data
2.1.1 Secondary Data
2.1.1.1 Key Data From Secondary Sources
2.1.2 Primary Data
2.1.2.1 Key Data From Primary Sources
2.2 Market Size Estimation
2.3 Market Breakdown and Data Triangulation
2.4 Assumptions for the Study
3. Executive Summary
3.1 Market Outlook
3.2 Segment Outlook
3.3 Competitive Insights
4. Global COVID-19 Diagnostic Kits Market Variables, Trends & Scope
4.1. Market Lineage Outlook
4.2. Penetration and Growth Prospect Mapping
4.3. Industry Value Chain Analysis
4.4. Cost Analysis Breakdown
4.5. Technology Overview
4.6. Regulatory Framework
4.6.1. Reimbursement Framework
4.6.2. Standards And Compliances
5. Global COVID-19 Diagnostic Kits Market Overview
5.1. Market Dynamics
5.1.1. Market Driver Analysis
5.1.1.1. Increasing focus of COVID-19 Diagnostic Kits Companies on Brand Protection
5.1.1.2. Untapped Opportunities in Emerging Regions
5.1.2. Market Restraint Analysis
5.1.2.1. High Cost Associated with Implementation of Predictive Analysis
5.1.3. Industry Challenges
5.1.3.1. Presence of Ambiguous Regulatory Framework
6. Global COVID-19 Diagnostic Kits Market Analysis Tools
6.1. Industry Analysis - Porter’s
6.1.1. Supplier Power
6.1.2. Buyer Power
6.1.3. Substitution Threat
6.1.4. Threat from New Entrants
6.1.5. Competitive Rivalry
6.2. Pestel Analysis
6.2.1. Political Landscape
6.2.2. Environmental Landscape
6.2.3. Social Landscape
6.2.4. Technology Landscape
6.2.5. Legal Landscape
6.3. Major Deals And Strategic Alliances Analysis
6.3.1. Joint Ventures
6.3.2. Mergers and Acquisitions
6.3.3. Licensing and Partnership
6.3.4. Technology Collaborations
6.3.5. Strategic Divestments
6.4. Market Entry Strategies
6.5. Case Studies
7. Global COVID-19 Diagnostic Kits Market, By Product Historical Analysis and Forecast 2020-2027 (USD Million)
7.1. RT-PCR Assay Kits
7.2. Immunoassay Test Strips
8. Global COVID-19 Diagnostic Kits Market, By Specimen Historical Analysis and Forecast 2020-2027 (USD Million)
8.1. Nasopharyngeal Swab
8.2. Oropharyngeal Swab
8.3. Nasal Swab
8.4. Others
9. Global COVID-19 Diagnostic Kits Market, By End User Historical Analysis and Forecast 2020-2027 (USD Million)
9.1. Hospitals
9.2. Diagnostics Centres
9.3 Others
10. North America COVID-19 Diagnostic Kits Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
10.1. Introduction
10.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
10.2.1. U.S.A
10.2.2. Canada
10.2.3. Mexico
10.3. Market Size (USD Million) Forecast for North America 2020-2027
11. Latin America COVID-19 Diagnostic Kits Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
11.1. Introduction
11.2. Regional Market Trends
11.3. Historical Market Size (USD Million) Analysis By Country, 2015-2019
11.3.1. Brazil
11.3.2. Venezuela
11.3.3. Argentina
11.3.4. Rest of Latin America
11.4. Market Size (USD Million) Forecast for Latin America 2020-2027
12. Europe COVID-19 Diagnostic Kits Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
12.1. Introduction
12.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
12.2.1. Germany
12.2.2. U.K
12.2.3. France
12.2.4. Italy
12.2.5. Spain
12.2.6. Russia
12.2.7. Poland
12.2.8. Switzerland
12.2.9. Rest of Western Europe
12.3. Market Size (USD Million) Forecast for Europe 2020-2027
13. Asia Pacific COVID-19 Diagnostic Kits Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
13.1. Introduction
13.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
13.2.1. Japan
13.2.2. China
13.2.3. Singapore
13.2.4. India
13.2.5. Australia and New Zealand
13.2.6. ASEAN
13.2.7. South Korea
13.2.8. Taiwan
13.2.9. Rest of Asia Pacific
13.3. Market Size (USD Million) Forecast for Asia Pacific 2020-2027
14. Middle East and Africa COVID-19 Diagnostic Kits Market Analysis 2015–2019 and Forecast 2020–2027 (USD Million)
14.1. Introduction
14.2. Historical Market Size (USD Million) Analysis By Country, 2015-2019
14.2.1. Saudi Arabia
14.2.2. UAE
14.2.3. South Africa
14.2.4. Egypt
14.3. Market Size (USD Million) Forecast for MEA 2020-2027
15. Company Profiles (Competition Dashboard, Competitors Deep Dive, Product Connected Devices and Disease Indication Portfolio, Financial Layouts)
15.1. Abbott Laboratories
15.1.1. Company Overview
15.1.2. Product Portfolio
15.1.3. SWOT Analysis
15.1.4. Financial Overview
15.1.5. Strategic Overview
15.2. Seegene
15.2.1. Company Overview
15.2.2. Product Portfolio
15.2.3. SWOT Analysis
15.2.4. Financial Overview
15.2.5. Strategic Overview
15.3. Mylab Discovery Solutions
15.3.1. Company Overview
15.3.2. Product Portfolio
15.3.3. SWOT Analysis
15.3.4. Financial Overview
15.3.5. Strategic Overview
15.4. BGI
15.4.1. Company Overview
15.4.2. Product Portfolio
15.4.3. SWOT Analysis
15.4.4. Financial Overview
15.4.5. Strategic Overview
15.5 SD Biosensor
15.5.1. Company Overview
15.5.2. Product Portfolio
15.5.3. SWOT Analysis
15.5.4. Financial Overview
15.5.5. Strategic Overview
15.6 BioFire Diagnostics
15.6.1. Company Overview
15.6.2. Product Portfolio
15.6.3. SWOT Analysis
15.6.4. Financial Overview
15.6.5. Strategic Overview
15.7. Cepheid
15.7.1. Company Overview
15.7.2. Product Portfolio
15.7.3. SWOT Analysis
15.7.4. Financial Overview
15.7.5. Strategic Overview
15.8. Co-Diagnostics GenMark Diagnostics
15.8.1. Company Overview
15.8.2. Product Portfolio
15.8.3. SWOT Analysis
15.8.4. Financial Overview
15.8.5. Strategic Overview
15.9. Guangzhou Wondfo Biotech
15.9.1. Company Overview
15.9.2. Product Portfolio
15.9.3. SWOT Analysis
15.9.4. Financial Overview
15.9.5. Strategic Overview
15.10. F. Hoffmann-La Roche
15.10.1. Company Overview
15.10.2. Product Portfolio
15.10.3. SWOT Analysis
15.10.4. Financial Overview
15.10.5. Strategic Overview
15.11 Qiagen
15.11.1. Company Overview
15.11.2. Product Portfolio
15.11.3. SWOT Analysis
15.11.4. Financial Overview
15.11.5. Strategic Overview
15.12. Quidel Corporation
15.12.1. Company Overview
15.12.2. Product Portfolio
15.12.3. SWOT Analysis
15.12.4. Financial Overview
15.12.5. Strategic Overview
15.13. Randox Laboratories
15.13.1. Company Overview
15.13.2. Product Portfolio
15.13.3. SWOT Analysis
15.13.4. Financial Overview
15.13.5. Strategic Overview
15.14. Shenzhen Bioeasy Biotechnology
15.14.1. Company Overview
15.14.2. Product Portfolio
15.14.3. SWOT Analysis
15.14.4. Financial Overview
15.14.5. Strategic Overview
15.15. Thermo Fisher Scientific
15.15.1. Company Overview
15.15.2. Product Portfolio
15.15.3. SWOT Analysis
15.15.4. Financial Overview
15.15.5. Strategic Overview
16. FutureWise SME Key Takeaway Points for Client
UK : +44 141 628 9353 US : +1 347 709 4931
OR
Excel Dataset
Infographics
PDF Report
Market Overview
PowerPoint Presentation
Consumer Perception and Procurement
Competitive Analysis
What’s Next
Market Data Forecast
Risks and Opportunity Assessment
Market Trends and Dynamics